ENG and heritable pulmonary arterial hypertension: It can be debated whether a patient with a pathological ACVLR1, ENG, and BMP9 mutation, that has led to HPAH and is known to cause HHT, per definition also has HHT based on genetics and clinical features are not yet visible, or that those patients may not develop HHT at all.